Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acinetobacter Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Large-scale testing (Phase 3)Study completedNCT03894046
What this trial is testing

Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

Who this might be right for
Acinetobacter Baumannii-calcoaceticus ComplexHospital-acquired Bacterial PneumoniaVentilator-associated Bacterial Pneumonia+2 more
Entasis Therapeutics 207
Not applicableEnded earlyNCT05210387
What this trial is testing

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionBloodstream InfectionSevere Infection+7 more
Hospital Moinhos de Vento 107
Large-scale testing (Phase 3)UnknownNCT01297894
What this trial is testing

Colistin Versus Colistin Plus Fosfomycin for Infections Caused by MDR Acinetobacter Baumannii

Who this might be right for
Drug Safety
Mahidol University 92
Not applicableStudy completedNCT00462579
What this trial is testing

Risk Factors for Carbapenem-resistant Acinetobacter Baumannii

Who this might be right for
Acinetobacter Infections
University of Pittsburgh 100
Large-scale testing (Phase 3)Study completedNCT00079989
What this trial is testing

Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms

Who this might be right for
Gram-Negative Bacterial Infections
Wyeth is now a wholly owned subsidiary of Pfizer 115
Early research (Phase 1)Looking for participantsNCT06801223
What this trial is testing

Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Who this might be right for
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Innoviva Specialty Therapeutics 48
Not applicableUnknownNCT06370299
What this trial is testing

Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the Patient

Who this might be right for
Multi-antibiotic Resistance
Region Skane 10,000
Post-approval studies (Phase 4)UnknownNCT05586815
What this trial is testing

Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection

Who this might be right for
Acinetobacter Infections
Mahidol University 94
Not applicableStudy completedNCT03477292
What this trial is testing

7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated Pneumonia

Who this might be right for
Ventilator Associated Pneumonia
Post Graduate Institute of Medical Education and Research, Chandigarh 41
Not applicableStudy completedNCT00524563
What this trial is testing

Clinical Outcomes and Global Epidemiology -Data Coordinating Center

Who this might be right for
Acinetobacter Infections
University of Pittsburgh 400
Not applicableLooking for participantsNCT07601711
What this trial is testing

Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort Study

Who this might be right for
Carbapenem-Resistant Acinetobacter Baumannii InfectionBloodstream InfectionPneumonia+1 more
Sichuan Provincial People's Hospital 200
Not applicableStudy completedNCT01041716
What this trial is testing

Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria

Who this might be right for
Drug Resistance, Microbial
Maimonides Medical Center 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07431307
What this trial is testing

Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

Who this might be right for
Ventilator Associated Bacterial Pneumonia (VABP)Hospital Acquired Bacterial Pneumonia (HABP)Blood Stream Infection+2 more
BioVersys AG
Not applicableUnknownNCT03680898
What this trial is testing

Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae
Meridian Bioscience, Inc. 1,200
Post-approval studies (Phase 4)Looking for participantsNCT05922124
What this trial is testing

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Who this might be right for
Carbapenem Resistant Bacterial InfectionAcinetobacter BacteremiaAcinetobacter Pneumonia
Rambam Health Care Campus 734
Early research (Phase 1)Study completedNCT02971423
What this trial is testing

Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous ETX2514 Administered in Healthy Subjects

Who this might be right for
Acinetobacter Baumannii Infection
Entasis Therapeutics 124
Not applicableStudy completedNCT00524290
What this trial is testing

Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol

Who this might be right for
Acinetobacter Infections
University of Pittsburgh 100
Not applicableUnknownNCT06282835
What this trial is testing

Eravacycline Combination Therapy for MRAB

Who this might be right for
Pulmonary InfectionPneumonia, BacterialAcinetobacter Baumannii
Fujian Medical University Union Hospital 20
120